Does MK-677 cause acne?
MK-677 can cause acne in some users, mainly via elevated IGF-1 and increased sebum production. Here's who's susceptible and how to manage it.
Updated May 22, 2026 · 4 min read
Yes, MK-677 can cause or worsen acne in a meaningful minority of users — typically people in their teens and twenties who are already acne-prone, or people running higher doses (20–25 mg) for extended periods. The main mechanism is sustained elevation of IGF-1, which increases sebum production and can drive comedonal and inflammatory acne. The effect is real but not universal; many users notice no skin change at all.
If you have a history of moderate-to-severe acne, particularly cystic or jawline acne sensitive to androgen fluctuations, MK-677 is a higher-risk choice than other GH-axis options.
Why MK-677 hits the skin
MK-677 (ibutamoren) is a ghrelin-receptor agonist that produces a sustained elevation of growth hormone and IGF-1 — distinct from injectable secretagogues, which produce more pulsatile, shorter-duration elevations. The chronic IGF-1 elevation is the key variable for skin.
IGF-1 affects skin in several ways:
- Increases sebocyte activity — the cells that produce sebum (skin oil). More IGF-1 means more sebum.
- Amplifies androgen signaling in sebocytes, which is why acne flares often correlate with androgen-sensitive periods (puberty, anabolic use, hormonal cycling)
- Drives keratinocyte proliferation, which can contribute to clogged pores
The result is a recipe for comedonal acne (blackheads, whiteheads) plus inflammatory acne in susceptible users — typically on the back, chest, shoulders, and jawline.
For the broader frame on MK-677, see MK-677 user experience review and MK-677 vs Ipamorelin.
Who's most susceptible
The risk isn't uniform across users. Higher risk profiles include:
- Younger users (teens, early twenties) with active sebaceous glands and naturally higher baseline androgen activity
- People with a personal or family history of acne, especially adult acne or cystic acne
- Users running higher doses (20–25 mg/day) for 8+ weeks
- Users stacking MK-677 with anabolic steroids or testosterone — the combined androgen and IGF-1 load is much more skin-active than either alone
- People in humid climates or sweating heavily from training — environmental amplification of an already-elevated sebum baseline
Lower risk profiles:
- Older users (35+) with quieter sebaceous activity
- People with naturally dry skin and no acne history
- Conservative dose users (10–12.5 mg/day) on shorter cycles
What MK-677 acne looks like
Typically:
- Onset 2–6 weeks into a cycle, not immediate
- Distribution on back, chest, shoulders, and jawline more than face
- Character comedonal (clogged pores, blackheads/whiteheads) plus some inflammatory lesions
- Severity mild to moderate in most users; cystic acne is uncommon but possible in the most susceptible
Sudden severe cystic acne mid-cycle is a reason to stop the cycle and consult a dermatologist — not a "push through it" situation.
Management while on cycle
If acne develops but you want to continue the cycle, in order of intervention:
- Daily salicylic acid or BPO cleanser for chest/back. Cheap, effective for comedonal acne, available over the counter.
- Adapalene 0.1% topical for jawline acne. Available OTC, well-tolerated, effective for both comedonal and mild inflammatory acne.
- Reduce dose. 10 mg/day often produces noticeably less skin effect than 20 mg/day while preserving most of the sleep and recovery benefits.
- Shorten the cycle. If 8 weeks is the plan and skin is breaking down at week 4, consider stopping at 6.
- Address dietary co-factors. High-glycemic foods, dairy, and whey isolates are documented contributors to acne in susceptible users. The IGF-1 from MK-677 stacks on top of any IGF-1 driven by diet.
- Don't add isotretinoin reflexively. Isotretinoin is a serious medication with its own side-effect profile. If acne is severe enough to warrant it, the right move is usually to stop the MK-677 cycle, not push through with strong systemic medication.
| Intervention | Effectiveness for MK-677 acne |
|---|---|
| Topical BPO / salicylic acid | Good for mild |
| Topical adapalene | Good for moderate |
| Dose reduction | Often most effective |
| Diet (dairy, sugar) | Moderate, individual-dependent |
| Oral antibiotics | Reserved for moderate-severe |
| Isotretinoin | Usually means stop the cycle |
For dose protocol detail and side-effect monitoring, see MK-677 water retention management and GH secretagogue side effects.
When to stop
Stop the cycle if:
- Acne becomes cystic or severely inflammatory
- Scarring is developing
- The acne is affecting quality of life or work
- OTC interventions haven't helped after 2–3 weeks
Skin usually returns to baseline within 4–8 weeks of stopping, mirroring the timeline of IGF-1 decline. Persistent acne after a cycle ends usually points to an underlying acne tendency that the cycle amplified rather than created.